Anrukinzumab Biosimilar (IL-13 Reference Antibody)
Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma.
Product Specifications
Target
Anrukinzumab Biosimilar (Anti-IL-13 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV815115 1.0 µg DNA
C19orf15 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details MBS6495886-01 0.2 mL
PRP4, CT (Serine/Threonine-protein Kinase PRP4 Homolog, PRP4 pre-mRNA Processing Factor 4 Homolog, PRP4 Kinase, PRPF4B, KIAA0536, PRP4H, PRP4K) (PE)
Sign In for Pricing
View Details MBS6495886-02 5x 0.2 mL
PRP4, CT (Serine/Threonine-protein Kinase PRP4 Homolog, PRP4 pre-mRNA Processing Factor 4 Homolog, PRP4 Kinase, PRPF4B, KIAA0536, PRP4H, PRP4K) (PE)
Sign In for Pricing
View Details 